These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28003273)

  • 1. EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia-like B-cell malignancies.
    Niss Arfelt K; Barington L; Benned-Jensen T; Kubale V; Kovalchuk AL; Daugvilaite V; Christensen JP; Thomsen AR; Egerod KL; Bassi MR; Spiess K; Schwartz TW; Wang H; Morse HC; Holst PJ; Rosenkilde MM
    Blood; 2017 Feb; 129(7):866-878. PubMed ID: 28003273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses.
    Gatto D; Paus D; Basten A; Mackay CR; Brink R
    Immunity; 2009 Aug; 31(2):259-69. PubMed ID: 19615922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBI2 mediates B cell segregation between the outer and centre follicle.
    Pereira JP; Kelly LM; Xu Y; Cyster JG
    Nature; 2009 Aug; 460(7259):1122-6. PubMed ID: 19597478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell localization: regulation by EBI2 and its oxysterol ligand.
    Gatto D; Brink R
    Trends Immunol; 2013 Jul; 34(7):336-41. PubMed ID: 23481574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxysterols direct B-cell migration through EBI2.
    Liu C; Yang XV; Wu J; Kuei C; Mani NS; Zhang L; Yu J; Sutton SW; Qin N; Banie H; Karlsson L; Sun S; Lovenberg TW
    Nature; 2011 Jul; 475(7357):519-23. PubMed ID: 21796211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBI2 operates independently of but in cooperation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center.
    Gatto D; Wood K; Brink R
    J Immunol; 2011 Nov; 187(9):4621-8. PubMed ID: 21948984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
    Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
    Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.
    Schena M; Larsson LG; Gottardi D; Gaidano G; Carlsson M; Nilsson K; Caligaris-Cappio F
    Blood; 1992 Jun; 79(11):2981-9. PubMed ID: 1375120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia.
    Mayer R; Logtenberg T; Strauchen J; Dimitriu-Bona A; Mayer L; Mechanic S; Chiorazzi N; Borche L; Dighiero G; Mannheimer-Lory A
    Blood; 1990 Apr; 75(7):1518-24. PubMed ID: 1690580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.
    Till KJ; Pettitt AR; Slupsky JR
    J Immunol; 2015 Mar; 194(5):2439-46. PubMed ID: 25632006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premalignant cell dynamics in indolent B-cell malignancies.
    Milpied P; Nadel B; Roulland S
    Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes.
    Airoldi I; Raffaghello L; Cocco C; Guglielmino R; Roncella S; Fedeli F; Gambini C; Pistoia V
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):144-54. PubMed ID: 14734463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T follicular helper cells have distinct modes of migration and molecular signatures in naive and memory immune responses.
    Suan D; Nguyen A; Moran I; Bourne K; Hermes JR; Arshi M; Hampton HR; Tomura M; Miwa Y; Kelleher AD; Kaplan W; Deenick EK; Tangye SG; Brink R; Chtanova T; Phan TG
    Immunity; 2015 Apr; 42(4):704-18. PubMed ID: 25840682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.
    Santanam U; Zanesi N; Efanov A; Costinean S; Palamarchuk A; Hagan JP; Volinia S; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12210-5. PubMed ID: 20566844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia.
    Kipps TJ; Tomhave E; Pratt LF; Duffy S; Chen PP; Carson DA
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5913-7. PubMed ID: 2503826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells generated by B-1 development can progress to chronic lymphocytic leukemia.
    Hayakawa K; Formica AM; Colombo MJ; Ichikawa D; Shinton SA; Brill-Dashoff J; Hardy RR
    Ann N Y Acad Sci; 2015 Dec; 1362():250-5. PubMed ID: 25907284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.
    Bedekovics T; Hussain S; Feldman AL; Galardy PJ
    Blood; 2016 Mar; 127(12):1564-74. PubMed ID: 26702068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
    Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
    Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses.
    Pereira JP; Kelly LM; Cyster JG
    Int Immunol; 2010 Jun; 22(6):413-9. PubMed ID: 20508253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.